Consensus Gentex Corporation

Equities

GNTX

US3719011096

Real-time Estimate Cboe BZX 01:04:26 2024-03-28 pm EDT 5-day change 1st Jan Change
36.22 USD -0.26% Intraday chart for Gentex Corporation -0.48% +10.95%

Evolution of the average Target Price on Gentex Corporation

Price target over the last 5 years

History of analyst recommendation changes

0d7a400f46beff18b6.Ec-UJSjT0JTy07tiuRzQrug9i5WL_GtbVl13Q5hUmqM.KYDQV2eAmcOghtI18X6HyL9NxcXblwQCNGo-Nd8V08FcuOxnaZuho6q_gw~2b12fe7a98466cce6d2fb4668990a53e
B. Riley Securities Raises Gentex's PT to $44 From $42 After Investor Day, Notes 'Robust' Growth; Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on Gentex to $35 From $31, Maintains Neutral Rating MT
B. Riley Raises Gentex's PT to $42 From $36 After Above-Consensus Q4 2023 Results, Maintains Buy Rating MT
JPMorgan Adjusts Gentex Price Target to $37 From $36, Maintains Neutral Rating MT
Goldman Sachs Trims Price Target on Gentex to $31 From $33, Maintains Neutral Rating MT
B. Riley Lowers Gentex's Price Target to $36 From $40, Notes Elevated Economic Uncertainty, Multiple Compression; Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on Gentex to $33 From $29, Maintains Neutral Rating MT
B, Riley Raises Gentex's PT to $40 From $35 After Higher-Than-Expected Q2 Results, Keeps Buy Rating MT
JPMorgan Adjusts Price Target on Gentex to $30 From $28, Maintains Neutral Rating MT
BofA Securities Upgrades Gentex to Neutral From Underperform MT
JPMorgan Adjusts Gentex's Price Target to $28 From $27, Keeps Neutral Rating MT
Goldman Sachs Adjusts Price Target on Gentex to $29 From $28, Maintains Neutral Rating MT
Goldman Sachs Adjusts Price Target on Gentex to $28 From $26, Maintains Neutral Rating MT
Goldman Sachs Upgrades Gentex to Neutral From Sell, Adjusts Price Target to $26 From $24 MT
Jefferies Lowers Gentex's Price Target to $33 From $36, Maintains Buy Rating MT
B. Riley Lowers Gentex's Price Target to $35 from $37.50, Says Production Headwinds Weigh on Q2 Results; Keeps Buy Rating MT
BNP Paribas Exane Initiates Coverage on Gentex With Outperform Rating MT
BofA Securities Adjusts Price Target on Gentex to $31 From $26, Keeps Underperform Rating MT
JPMorgan Adjusts Gentex Price Target to $31 From $33, Maintains Neutral Rating MT
Goldman Sachs Lowers Gentex's Price Target to $25 From $28, Maintains Sell Rating MT
B. Riley Lowers Gentex's Price Target to $37.50 from $41, Says Supply Chain Headwinds Likely to Persist Through H1; Keeps Buy Rating MT
GENTEX : JPMorgan Adjusts Gentex's Price Target to $37 from $34, Keeps Neutral Rating MT
GENTEX : Goldman Sachs Adjusts Gentex's PT to $30 from $32, Keeps Sell Rating MT
GENTEX : JPMorgan Adjusts Gentex's Price Target to $34 from $37, Keeps Neutral Rating MT
GENTEX : KeyBanc Adjusts Gentex's Price Target to $40 from $43, Keeps Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
36.31 USD
Average target price
38.6 USD
Spread / Average Target
+6.31%
High Price Target
44 USD
Spread / Highest target
+21.18%
Low Price Target
35 USD
Spread / Lowest Target
-3.61%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Gentex Corporation

B. Riley
Goldman Sachs
JPMorgan Chase
BofA Securities
Jefferies & Co.
BNP Paribas Exane
KeyBanc Capital Markets
Seaport Global Securities
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings